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Most pathogenesis studies focus on pathogen virulence
attributes that mediate host colonization, toxicity, or immune
evasion. Some studies focus on how pathogens employ active
mechanisms to acquire essential nutrients such as iron and
vitamins from the host by producing siderophores or avidins. In
order to prevent pathogen nutrient acquisition, host cells employ a
process called nutritional immunity to sequester these nutrients,
particularly iron, from invading pathogens [1]. However, relatively
little attention has been paid to understanding the mechanisms
by which pathogens parasitize energy and catabolic substrates
from the host even though several host and pathogen metabolic
genes, including those in central carbon metabolism, are regularly
identified as required for growth in the host [2,3]. This issue is
particularly important for intracellular pathogens that must
compete with the host cell for energy and nutrient sources.
How and where do intracellular pathogens obtain sufficient
amounts of energy and nutrients to support their replication?
Pathogens may either parasitize existing energy stores or
manipulate the host cell to create usable energy and anabolic
precursor metabolites. Several recent studies have identified the
host AMP-activated protein kinase (AMPK) and mammalian
target of rapamycin (mTOR) kinases as two important regulators
of cellular metabolism whose activities are often altered during
infection. However, the AMPK/mTOR pathway also regulates
autophagy, which can destroy cytosolic pathogens. While the
evasion of autophagy by pathogens is well appreciated, recent
work suggests that both the AMPK/mTOR pathway and
autophagy itself can provide intracellular metabolites that support
intracellular pathogen replication.
AMPK and mTOR Regulate Energy Homeostasis
During times of limited nutrient availability, intracellular ATP
levels fall, with a corresponding increase in AMP levels. Within
eukaryotic cells the increased AMP:ATP ratio induces AMPK
activity, which in turn initiates a series of signaling events that
stimulate energy and nutrient acquisition [4]. For example,
activated AMPK stimulates glycolytic flux, increases glucose
uptake, and induces fatty acid oxidation (Figure 1). Together
these events allow the cell to use its existing metabolic stores and
also acquire new sources of energy. At the same time, activated
AMPK limits energy consuming processes. Activated AMPK
conserves energy by globally reducing protein synthesis, which
perhaps is the most energy-intensive process in eukaryotic cells.
AMPK limits protein synthesis by antagonizing the mTOR kinase,
and mTOR kinase activity is necessary for formation of the elF4F
complex, which is critical for translation initiation. In addition,
mTOR and AMPK inversely regulate the recycling of existing
intracellular metabolites through their effects on autophagy.
Active AMPK stimulates autophagic breakdown of macromolec-
ular complexes in the cell, thus producing energy and nutrients. In
contrast, active mTOR suppresses autophagy to promote cell
growth and proliferation. In a simplified view, when energy is
low AMPK is active and mTOR is inhibited. This stimulates
energy-producing processes and inhibits energy consumption
thereby providing sufficient energy to support cell viability.
Although AMPK and mTOR have additional roles outside of
cellular metabolism, here we focus on the effects of AMPK and
mTOR on cellular metabolism during infection by intracellular
pathogens.
Manipulation of Both AMPK and mTOR by
Intracellular Pathogens
In order to achieve optimal levels of proliferation, many
pathogens must manipulate activity of AMPK and mTOR.
Interestingly, several viral pathogens have evolved strategies that
allow for the induction of both AMPK and mTOR activity. For
example, infection with human cytomegalovirus (HCMV) increas-
es both AMPK and mTOR activity [5]. To acquire sufficient
energy for viral growth, HCMV infection increases glycolytic
flux in an AMPK-dependent manner [2,6]. However, HCMV
must strictly regulate AMPK activity during infection, as treatment
of infected cells with chemicals that strongly activate or inhibit
AMPK can limit viral replication [6,7]. Interestingly, HCMV
replication also requires fatty acid synthesis, which should be
inhibited when AMPK is activated. Yet fatty acid synthesis is
maintained during HCMV infection through a mechanism that
requires mTOR activation [8]. How does HCMV allow for the
activation of both AMPK and mTOR? The answer lies in part
in the activity of the HCMV UL38 protein (pUL38). pUL38
binds and inhibits the TSC1/2 complex, which is necessary for
antagonism of mTOR by activated AMPK [9]. HCMV thus
uncouples AMPK/mTOR signaling resulting in increased energy
production and lipid synthesis, both of which contribute to virus
replication.
Simian virus 40 (SV40) infection also stimulates both AMPK
and mTOR activity. SV40 small T antigen is both necessary and
sufficient for AMPK activation [10,11]. This function of small T
antigen may provide critical nutrients needed for viral replication.
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mTOR activity is induced early in infection but inhibited as
infection progresses. The mechanism driving the early induction of
mTOR activity is unknown, but may be the result of Akt
activation by the SV40 T antigens. However, the inhibition of
mTOR activity during the late stage of infection is due to the
effects of the SV40 small T antigen [11]. While activated AMPK
would seemingly reduce SV40 protein synthesis, the expression of
SV40 late proteins is driven by an internal ribosome entry site
(IRES) that allows for efficient late mRNA translation when
mTOR is inhibited [12]. It is likely that other pathogens employ
active mechanisms to balance AMPK and mTOR signaling to
allow for both catabolic and anabolic processes essential for
pathogen replication, similar to HCMV and SV40.
Inhibiting AMPK or Inducing mTOR Can Provide
Essential Substrates for Pathogen Replication
Enveloped viruses require host lipids to generate the virion
membrane. Activated mTOR stimulates fatty acid and lipid
synthesis, and therefore could prove beneficial for virus assembly.
In fact, host lipid metabolism is essential for the hepatitis C virus
(HCV) life cycle and is highly regulated during infection [13,14].
HCV infection limits AMPK activity and chemical induction of
AMPK suppresses viral replication and inhibits fatty acid synthesis
in HCV-infected cells [15]. Consistent with AMPK suppression,
mTOR activity is increased during HCV infection through
increased Akt signaling and decreased TSC1/2 expression [16].
Figure 1. Infection by diverse pathogens impacts AMPK and mTOR signaling. Several intracellular pathogens manipulate the AMPK/mTOR
pathway during infection through either directly targeting AMPK or mTOR or by targeting the upstream or downstream pathways. Depicted here are
specific points of manipulation in the mTOR/AMPK pathway by human cytomegalovirus (HCMV), hepatitis C virus (HCV), Rift Valley fever virus (RVFV),
simian virus 40 (SV40), Leishmania, and Francisella species. The table summarizes the resulting effects on the activities of mTOR and AMPK from
infection by the specific pathogen.
doi:10.1371/journal.ppat.1003552.g001
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However, this raises the question of how HCV acquires significant
energy sources for viral replication in an AMPK-inhibited,
mTOR-activated metabolic state? The answer may be the
temporal regulation of host signaling and nutrient usage. Glucose
import is required for viral replication and glycolytic flux is
induced early during HCV infection [14,17]. The products of
glycolysis are likely diverted to fatty acid synthesis, as TCA flux
and oxidative phosphorylation are reduced in HCV-infected cells
[14,18]. Later during infection, glucose uptake is reduced, while b-
oxidation and amino acid catabolism are increased [14]. It is
therefore possible that HCV temporally regulates AMPK and
mTOR activity to achieve significant viral protein translation
and lipid production, yet still obtain sufficient energy to support
virus replication. Some bacterial pathogens may benefit from
inhibiting AMPK and activating mTOR by inducing lipid
synthesis, as Mycobacterium tuberculosis and Chlamydia trachomatis
utilize fatty acids derived from lipid droplets [19,20]. However, it
is unknown how these bacteria affect host metabolic signaling to
acquire nutrients.
AMPK activation also inhibits the replication of several
arboviruses, including Rift Valley fever virus (RVFV) [21]. RVFV
replication can be rescued in the presence of activated AMPK
by providing cells with excess palmitate [21]. This suggests that
AMPK inhibition is required to provide lipids essential for viral
replication. The HIV-1 Tat protein inhibits the host SIRT1
protein resulting in AMPK inhibition [22]. Interestingly,
AMPK induction inhibits lytic HIV replication, but is involved
in reactivation of latent HIV genomes suggesting that AMPK
activity may have different roles in acute and persistent infection
[23].
AMPK Activation May Benefit Replication of
Diverse Pathogens
It takes a lot of energy to make hundreds, thousands, or
potentially millions of new parasites, bacteria, or viruses. It seems
logical that intracellular pathogens that undergo significant
intracellular growth would activate AMPK due to the energetic
demands placed on the infected cell. Activation of AMPK
could provide several benefits for intracellular pathogens. The
increased glucose uptake, glycolysis, and fatty acid breakdown
would increase available intracellular energy and nutrient pools
needed for pathogen replication. For example, Leishmania donovani
amastigotes (the parasitic form that grows inside macrophages)
preferentially generate energy through fatty acid oxidation and
amino acid catabolism [24], suggesting L. donovani acquires fatty
acids and amino acids from the infected host cell. Consistent with
this finding, transcriptomic analysis of macrophages infected with
the related parasite Leishmania major suggests that infected cells
increase glucose transport, glycolysis, and starch degradation [25].
While it is currently unknown how Leishmania alters host metabolic
processes, a reasonable hypothesis is that intracellular Leishmania
activates AMPK to benefit parasite replication. Activated AMPK
could stimulate increased glucose utilization and autophagy, thus
creating elevated levels of anabolic precursor pools for parasite
growth. Parasite replication requires the Leishmania protein GP63,
which cleaves and inactivates mTOR to reduce type I interferon
production, thus AMPK activation could further benefit parasite
replication by inhibiting mTOR [26]. Viral pathogens may also
benefit from AMPK activation. Measles virus requires b-oxidation
for replication [27], but it is unknown if the virus manipulates
AMPK for energy generation. It would be interesting to determine
if these intracellular pathogens and others induce AMPK to
generate energy and nutrients for growth.
Autophagy Provides Intracellular Pathogens with
Nutrients
Autophagy is an essential cellular process that recycles cellular
constituents from macromolecular complexes under conditions
of nutrient stress. As discussed above, autophagy is positively
regulated by AMPK and negatively regulated by mTOR.
However, autophagy also functions as a host defense mechanism
that destroys intracellular pathogens through a process termed
xenophagy. While generally viewed as detrimental for intracellular
pathogens, some bacteria and viruses use autophagosomes as a
replicative niche [28]. Whether these pathogens benefit or
simply tolerate residing in autophagosomes remains unclear.
However, it may be that replicating in a site where free nutrients
are accumulating provides pathogens with a competitive edge
for the acquisition of nutrients. This concept is supported by
recent evidence that intracellular pathogens may use autophagy to
acquire energy and nutrients for growth. Dengue virus–induced
autophagy degrades lipid droplets. This increases free fatty acids
levels in the cell and stimulates b-oxidation, which is required for
efficient dengue virus replication [29]. Similarly, we have found
that Francisella tularensis growth is impaired in autophagy-deficient
host cells. Bacterial growth was restored in autophagy-deficient
cells by supplying the infected cells with excess pyruvate or amino
acids. Since F. tularensis replicates within the cytosol of host cells,
our results suggest that intracellular F. tularensis uses autophagy to
increase cytosolic nutrient pools that support bacterial growth
[30]. Interestingly, F. tularensis avoids engulfment by classical
autophagosomes [31] and instead induces an alternative form of
autophagy that is required for bacterial replication [30]. It is
attractive to speculate that other intracellular pathogens manip-
ulate autophagy to avoid xenophagic destruction, while simulta-
neously benefiting from autophagy-derived nutrients.
Conclusion
AMPK and mTOR are critical regulators of host cell
metabolism making them logical targets for manipulation by
invading pathogens. The energetic burden of the host cell to create
hundreds or more pathogens should deplete cellular ATP levels,
thus activating AMPK. AMPK induction stimulates host processes
to produce energy and nutrients that the pathogen could then steal
from the host. This idea suggests AMPK activation may be a
common theme among infection by successful intracellular
pathogens. On the other hand, mTOR signaling stimulates
protein and lipid synthesis, which could be beneficial for many
viral pathogens; whereas mTOR modulation is likely less
important for free-living bacteria pathogens and parasites that
supply their own biosynthetic and translation machinery. Identi-
fying what nutrient sources are required for intracellular growth
and how host metabolic signaling is manipulated by infection is
being investigated in viral pathogenesis, yet remains poorly
understood in bacterial and parasitic pathogenesis.
Manipulating host metabolism is an attractive approach to
controlling infection as targeting the host rather than the pathogen
should considerably reduce the ability of pathogens to develop
drug resistance. Several drugs already in clinical use target the
AMPK or mTOR kinases to treat diseases such as cancer and
diabetes. The studies described above suggest that these drugs
may have additional uses in treating infections with intracellular
pathogens. As our understanding of pathogen manipulation of
host metabolism grows, it may also be possible to develop
inhibitors of specific host metabolic pathways hijacked by
intracellular pathogens. Identifying the essential nutrients required
PLOS Pathogens | www.plospathogens.org 3 October 2013 | Volume 9 | Issue 10 | e1003552
for intracellular pathogen proliferation and the host pathways
manipulated to acquire these nutrients will be a significant step in
understanding the requirements for viral, bacterial, and parasitic
pathogenesis and identifying new targets for novel therapeutics.
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